Lyka Labs Limited (NSE:LYKALABS)
99.12
+0.22 (0.22%)
Sep 9, 2025, 9:29 AM IST
Lyka Labs Revenue
Lyka Labs had revenue of 330.25M INR in the quarter ending June 30, 2025, with 9.67% growth. This brings the company's revenue in the last twelve months to 1.38B, up 21.50% year-over-year. In the fiscal year ending March 31, 2025, Lyka Labs had annual revenue of 1.35B with 27.04% growth.
Revenue (ttm)
1.38B
Revenue Growth
+21.50%
P/S Ratio
2.56
Revenue / Employee
2.76M
Employees
499
Market Cap
3.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.35B | 287.16M | 27.04% |
Mar 31, 2024 | 1.06B | 167.66M | 18.75% |
Mar 31, 2023 | 894.17M | -950.50M | -51.53% |
Mar 31, 2022 | 1.84B | 1.16B | 169.25% |
Mar 31, 2021 | 685.11M | 118.05M | 20.82% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
Lyka Labs News
- 5 weeks ago - Lyka Labs shares fall 3% as Q1 net profit falls 20% YoY; Check earnings - Business Upturn
- 5 months ago - Lyka Labs secures patent for Pregabalin Gel 8% to treat diabetic neuropathic pain - Business Upturn